Author

Lorenzo Serra

The Wistar InstituteORCID 0000-0002-7602-9606Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Alexander M. PriceiD· 1 shared Alison YuiD· 1 shared Claire M O'Brien· 1 shared Clayton J. OtteriD· 1 shared Daniel T. ClaiborneiD· 1 shared Molly R. PattersoniD· 1 shared Reyes Acosta· 1 shared Susan Reich WeissiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexander M. PriceORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating viruses

Lorenzo Serra, Claire M O'Brien, Molly R. Patterson, Clayton J. Otter, Alison Yu, Reyes Acosta, Daniel T. Claiborne, Susan Reich Weiss, Alexander M. Price

This study shows that inhibiting RNA splicing reduces viral replication in splicing-dependent viruses like adenovirus, HSV-1, and influenza A, suggesting a new antiviral strategy.

bioRxiv · Jun 27, 2026 · PreprintMicrobiology